Details of the Drug Reposition

General Information of This Drug (ID: DMXLS6K)

Drug Name
Rivo-cel   DMXLS6K
Synonyms BPX-501
Drug Type
Cell therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2/3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Myelodysplastic syndrome DISYHNUI 2A37 Phase 2/3 [1]
Acute myeloid leukaemia DIS0BM1I 2A60 Phase 2/3 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03699475) Study of Haplo-HSCT + Rivogenlecleucel vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML or MDS (THRIVE). U.S. National Institutes of Health.